Literature DB >> 8325605

Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor.

K M Win1, F Charlotte, A Mallat, D Cherqui, N Martin, P Mavier, A M Preaux, D Dhumeaux, J Rosenbaum.   

Abstract

We assessed the effect of transforming growth factor-beta 1 on the proliferation of human Ito cells. Ito cells in their myofibroblastlike phenotype were grown from explants of human liver and were characterized with electron microscopy and positive immunostaining for desmin and smooth muscle alpha-actin. Transforming growth factor-beta 1 was mitogenic for human Ito cells whatever the culture conditions, although it was, as previously described, inhibitory of growth for rat Ito cells. The mitogenic effect of transforming growth factor-beta 1 was likely due to induction of autocrine platelet-derived growth factor chain secretion by Ito cells themselves because (a) the mitogenic effect of transforming growth factor-beta 1 was blocked by specific platelet-derived growth factor antibodies, (b) transforming growth factor-beta 1 increased platelet-derived growth factor-A chain messenger RNA expression and platelet-derived growth factor-AA secretion by human Ito cells and (c) human Ito cells expressed the alpha-type platelet-derived growth factor-A receptor messenger RNA. Exogenous platelet-derived growth factor-AA was also mitogenic for human Ito cells, mimicking the effect of transforming growth factor-beta 1. Our data suggest that results obtained with rat Ito cells must be extrapolated with caution to human ones. The mitogenic effect of transforming growth factor-beta 1 on human Ito cells probably has pathophysiological relevance because transforming growth factor-beta 1 has been demonstrated in vivo at sites of active liver fibrogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325605

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  Effect of anti-fibrosis compound on collagen expression of hepatic cells in experimental liver fibrosis of rats.

Authors:  Ling-Tai Wang; Bin Zhang; Jian-Jie Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Involvement of nuclear factor-kappaB in endothelin-A-receptor-induced proliferation and inhibition of apoptosis.

Authors:  M Mangelus; R Galron; Z Naor; M Sokolovsky
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

Review 3.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

4.  Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.

Authors:  Karim Si-Tayeb; Arnaud Monvoisin; Claire Mazzocco; Sébastien Lepreux; Marion Decossas; Gaëlle Cubel; Danièle Taras; Jean-Frédéric Blanc; Derrick R Robinson; Jean Rosenbaum
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

Review 5.  Mechanisms of hepatic fibrogenesis.

Authors:  Ursula E Lee; Scott L Friedman
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

6.  Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts.

Authors:  S Blazejewski; B Le Bail; L Boussarie; J F Blanc; L Malaval; K Okubo; J Saric; P Bioulac-Sage; J Rosenbaum
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

7.  Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury.

Authors:  Sabrina Fan; Ching-Feng Weng
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

8.  Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway.

Authors:  A Mallat; L Fouassier; A M Préaux; C S Gal; D Raufaste; J Rosenbaum; D Dhumeaux; C Jouneaux; P Mavier; S Lotersztajn
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.

Authors:  Chundong Yu; Fen Wang; Chengliu Jin; Xinqiang Huang; David L Miller; Claudio Basilico; Wallace L McKeehan
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Epigallocatechin-3-gallate inhibits growth of activated hepatic stellate cells by enhancing the capacity of glutathione synthesis.

Authors:  Yumei Fu; Shizhong Zheng; Shelly C Lu; Anping Chen
Journal:  Mol Pharmacol       Date:  2008-01-29       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.